Uncategorised - European Medical Journal

GLP-1 Drugs Linked to Lower Dementia and Stroke Risk

GLP-1 receptor agonists like semaglutide and tirzepatide are linked to significantly lower risks of dementia, ischemic stroke, and all-cause mortality in adults with type 2 diabetes and obesity, according to a large US cohort study.

ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity

Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…

Malaria Prevention in Pregnancy Threatened by Rising Drug Resistance

A major global study confirms that malaria resistance diminishes IPTp-SP’s antimalarial benefits but not its impact on low birthweight, prompting urgent calls for new preventive strategies.

Study Links IBS to Depression and Sexual Dysfunction

New research shows IBS patients suffer higher depression and worse sexual health compared to healthy individuals, highlighting the condition’s broad impact on wellbeing.

Intense Pulsed Light Outperforms Nicotinamide in Acne Treatment Study

Both treatments resulted in significant improvement in inflammatory acne lesions; however, IPL yielded better overall outcomes.

Music Therapy Offers Relief for Distress in NHS Dementia Wards

Music therapy shows promise for reducing distress in patients with dementia on NHS wards, supporting safer, more compassionate care.

Urodynamics Offers No Added Benefit for Bladder Care

From an economic perspective, urodynamics added £463 in cost and yielded a modest 0.011 additional quality-adjusted life-years.

Carbon Build-up in Lungs Linked to COPD Severity

Macrophages in COPD lungs show elevated carbon loads, larger cell size, and enhanced inflammation, highlighting a potential driver of disease progression.

Dual Vaccine Shows Strong Immune Response in Adults Over 50

A new multicomponent vaccine targeting both seasonal influenza and SARS-CoV-2 has demonstrated noninferior immunogenicity and acceptable safety in adults aged 50 years and older, according to results from a Phase III randomized trial.

Monitoring Nocturnal Scratching for Atopic Dermatitis Care with Wearables

Wearable and touchless technologies reliably measure nocturnal scratching in atopic dermatitis, supporting at-home monitoring for better care.